Statistical analysis plan (SAP) for the Very Early Rehabilitation in Speech (VERSE) after stroke trial: an international 3-arm clinical trial to determine the effectiveness of early,intensive,prescribed,direct aphasia therapy

Abstract

Background

Limited evidence exists to support very early intensive aphasia rehabilitation after stroke. VERSE is a PROBE trial designed to determine whether two types of intensive aphasia therapy, beginning within 14 days of acute stroke, provide greater therapeutic and cost-effectiveness than usual care.

Objective

To publish the detailed statistical analysis plan for the VERSE trial prior to unblinding. This statistical analysis plan was based on the published and registered VERSE trial protocol and was developed by the blinded steering committee and management team, led by the trial statistician. This plan was developed using outcome measures and trial data collection forms.

Results

The VERSE statistical analysis plan is consistent with reporting standards for clinical trials and provides for clear and open reporting.

Conclusions

Publication of a statistical analysis plan serves to reduce potential trial reporting bias and outlines transparent pre-specified analyses. Australian New Zealand Clinical Trials Registry (ANZCTR) Registration number: ACTRN12613000776707; Universal Trial Number (UTN) is U1111-1145-4130.

Keywords

Aphasia Stroke Rehabilitation Statistical analysis plan Randomised controlled trial

Get full access to this article

View all access options for this article.

References

Godecke

Armstrong

Ciccone

et al.

The design of “A prospective multicentre, randomised controlled trial of Very Early Rehabilitation in Speech (VERSE) in patients with aphasia following acute stroke.”. Int J Stroke 2016; 11: 586–592.

Kertesz

. Western Aphasia Battery–Revised, New York: NCS Pearson, 2007.

Enderby

Wood

Wade

. The Frenchay Aphasia Screening Test, 3rd ed. London: Stass Publications, 2013.

National Institute of Health Stroke Scale (NIHSS), http://www.nihstrokescale.org/.

Rankin

. Cerebral vascular accidents in patients over the age of 60. Scot Med J 1957; 2: 200–215.

Bamford

Sandercock

Dennis

Burn

Warlow

. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991; 337: 1521–1526.

Ward

Conroy

. Validity, reliability and responsivity of the Royal Brisbane Hospital Outcome Measure for Swallowing. Asia Pac J Speech Lang Hear 1999; 4: 109–129.

Perry

Morris

Unsworth

et al.

Therapy outcome measures for allied health practitioners in Australia: the AusTOMs. Int J Qual Health Car 2004; 16: 285–291.

Kaplan

Goodglass

Weintraub

. Boston Naming Test, 2nd ed. New York: NCS Pearson, 2000.

10.

Brookshire

Nicholas

. Presence completeness and accuracy of main concepts in the connected speech of non-brain injured in adults. J Speech Hear Res 1995; 38: 145–156.

11.

Nicholas

Brookshire

. Presence completeness and accuracy of main concepts in the connected speech of non-brain injured in adults. J Speech Hear Res 1995; 38: 145–156.

12.

Boles

. Conversational discourse analysis as a method of evaluating progress in aphasia: a case report. J Com Dis 1998; 31: 261–274.

13.

Ellis

Rosenbek

Rittman

Boylstein

. Recovery of cohesion in narrative discourse after left-hemisphere stroke. J Rehab Res Dev 2005; 42: 737–746.

14.

Godecke

Ciccone

Granger

et al.

A comparison of aphasia therapy outcomes before and after very early rehabilitation following stroke. Int J Lang Com Dis 2014; 49: 149–161.

15.

Godecke

Rai

Ciccone

Armstrong

Granger

Hankey

. Amount of therapy matters in very early aphasia rehabilitation after stroke: a clinical prognostic model. Sem Speech Lang 2013; 34: 239–251.

16.

Ciccone

Cream

West

et al.

Constraint-induced aphasia therapy (CIAT): a randomised controlled trial in very early stroke rehabilitation. Aphasiology 2016; 30: 566–584.

17.

Hilari K, Byng S, Lamping DL and Smith SC. Stroke and aphasia quality of life scale-39 (SAQOL-39) - Evaluation of acceptability, reliability, and validity. Stroke 2003; 34(8): 1944–1950. doi: 10.1161/01.STR.0000081987.46660.ED.

18.

Benaim

Cailly

Pélissier

Pérennou

. Validation of the aphasic depression rating scale. Stroke 2004; 35: 1692.

19.

Lazar

Minzer

Antoniello

Festa

Krakauer

Marshall

. Improvement in aphasia scores after stroke is well predicted by initial severity. Stroke 2010; 41: 1485–1488.

20.

R Core Team (2014). R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, www.R-project.org/ (accessed 20 August 2010).

21.

IBM Corp. IBM SPSS Statistics, Version 25.0, Armonk: IBM Corp, 2017.

22.

Boutron

Moher

Altman

Schultz

Ravaud

. for the CONSORT group. Extending the CONSORT Statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 2008; 148: 295–309.

23.

Chan

A-W

Tetzlaff

Altman

et al.

SPIRIT 2013 Statement: defining standard protocol items for clinical trials. Ann Intern Med 2013; 158: 200–207.

24.

Chan

A-W

Tetzlaff

Gøtzsche

et al.

SPIRIT 2013 Explanation and Elaboration: guidance for protocols of clinical trials. BMJ 2013; 346: e7586.

25.

White

Royston

Wood

. Multiple imputation using chained equations: issues and guidance for practice. Stat Med 2011; 30: 377–399.

26.

White

Horton

Carpenter

Pocock

. Strategy for intention to treat analysis in randomised trials with missing outcome data. BMJ 2011; 342: d40.

27.

National Research Council. The prevention and treatment of missing data in clinical trials, Washington, DC: The National Academies Press, 2010.